中西医结合治疗老年不稳定型心绞痛的临床疗效评价被引量：1

下载PDF

导出

摘要目的:探讨中西医结合治疗老年不稳定型心绞痛的临床疗效及价值。方法:回顾性分析2010年11月至2011年11月在我科接受治疗的86例老年UAP患者的临床资料,根据其治疗方案不同将86例患者随机分为观察组和对照组各43例,对照组给予西医常规治疗,观察组在对照组基础上给予丹红注射液治疗,观察两组患者心电图疗效、心绞痛疗效、心肌功能改善情况及不良反应情况,并进行对比分析。结果:观察组心电图总有效率为81.40%,明显高于对照组的62.79%,组间比较有显著差异(P<0.05);观察组心绞痛总有效率为93.02%,明显高于对照组的81.40%,组间比较有显著差异(P<0.05);治疗后观察组SV和LVEF均较治疗前增高(P<0.05);治疗后观察组SV和LVEF均高于对照组(P<0.05),且两组不良反应均较轻微,未能影响继续治疗。结论:中西医结合治疗老年UAP疗效优于单一西药治疗,具有疗效好、见效快、标本兼治等诸多优点,是目前治疗老年UAP的一种较佳治疗方案,值得临床推广应用。

作者胡斌

机构地区中国人民解放军第

出处《河北医学》 CAS 2013年第7期1073-1076,共4页 Hebei Medicine

关键词老年不稳定型心绞痛丹红注射液西医治疗

分类号 R541.4 [医药卫生—心血管疾病]

引文网络
相关文献

参考文献5

1BanachM, Rysz J, Goch A, et al. The role of trimetidine after acute myocardial infarction [ J ]. Curt Vasc Pharmacol, 2008,6(4) :282-291.
2柯元南,陈纪林.不稳定性心绞痛和非ST段抬高心肌梗死诊断与治疗指南[J].中华心血管病杂志,2007,35(4):295-304. 被引量：2146
3曹建恒.通心络胶囊治疗老年不稳定型心绞痛临床观察[J].中西医结合心脑血管病杂志,2009,7(3):265-266. 被引量：16
4Jackson G. Stable angina: drugs, angioplasty or surgery [J]. Eu Heart,2000,18(Supp IB) :B2-B10.
5MailliM, KleinWW. Efficacy and tolerability of trimetazi- dine instable angina: a meta-analysis of randomized, doub- le- blind, trolled trials [ J ]. Coron ArteryDis, 2003, 14 (2) : 171-179.

二级参考文献26

1李旭军,廖绍芳.益气活血治疗急性冠脉综合征临床回顾研究[J].现代中西医结合杂志,2006,15(8):997-999. 被引量：17
2李小鹰.阿司匹林在动脉硬化性心血管疾病中的临床应用:中国专家共识(2005)[J].中华心血管病杂志,2006,34(3):281-284. 被引量：194
3Braunwald E, Antman EM, Beasley JW, et al. ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction-summary article: a report of the American College of Cardiology/American Heart Association task force on practice guidelines(Committee on the Management of Patients With Unstable Angina). J Am Coll Cardiol,2002, 40(7) :1366-1374.
4Bertrand ME, Simoons ML, Fox KA, et al. Management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J,2002,23 ( 23 ) : 1809 -1840.
5Erhardt L, Herlitz J, Bossaert L, et al. Task force on the management of chest pain. Eur Heart J, 2002, 23 ( 15 ) : 1153-1176.
6CAPRIE Steering Committee. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee. Lancet, 1996, 348(9038) :1329-1339.
7Yusuf S, Zhao F, Mehta SR, et al. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med, 2001 , 345 ( 7 ) :494-502.
8Mehta SR, Yusuf S, Peters RJ, et al. Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study. Lancet, 2001, 358(9281):527-533.
9Simoons ML, GUSTO IV-ACS Investigators. Effect of glycopmtein Ⅱb/Ⅲa receptor blocker abciximab on outcome in patients with acute coronary syndromes without early coronary revascularisation:the GUSTO IV-ACS randomised trial. Lancet, 2001,357(9272) :1915-1924.
10Platlat Receptor Inhibitor in Ischemic Syndrome Management(PRISM) study investigator. A comparison of aspirin plus tirofiban with aspirin plus heparin for unstable angina. Platelet Receptor Inhibition in Ischemic Syndrome Management ( PRISM )Study Investigators. N Engl J Med, 1998, 338(21 ) :1498-1505.